Note sull'episodio
Discussing the FDAs recent reversal on compounding Terzepitide while they re-evaluate the shortage situation. This and more on today's episode.
Parole chiave
shortagecompounded medicationsbranded medicationsTerzepitidemanufacturingFDAstop manufactureconsequencesreversal